Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Researchers have developed an engineered adeno-associated virus (AAV) vector that yields high transduction of brain vascular pericytes and smooth muscle cells.

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a five-year, $14 million per year grant from the National Institute of Allergy and Infectious Diseases (NIAID) to

September 14, 2024

The impacts and implications of virtual consultations in cancer genetics amid the COVID-19 pandemic

Authors assessed the opportunities and challenges brought on by the swift transition to virtual consultations.

August 4, 2023

FDA finalizes COVID-era guidance, extending flexibility for some remote monitoring devices

Dive Brief: The Food and Drug Administration published an enforcement policy for non-invasive remote monitoring devices on Thursday as part of its transition away from

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.